https://www.acumenresearchandconsulting.com/
Home Services Industry Services Press Releases About Us Blogs Report Store Contact us

Immunoassay Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032

Published : Oct 2024

Report ID: ARC1277

Pages : 250

Format : Immunoassay Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032

CHAPTER 1. Industry Overview of Immunoassay Market

1.1. Definition and Scope

1.1.1. Definition of Immunoassay

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Immunoassay Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Immunoassay Market By Technology

1.2.3. Immunoassay Market By Product

1.2.4. Immunoassay Market By Specimen

1.2.5. Immunoassay Market By Application

1.2.6. Immunoassay Market By End-Use

1.2.7. Immunoassay Market By Region

 

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

 

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Immunoassay Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Immunoassay Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2023

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

 

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023

4.2. R&D Status of Major Manufacturers in 2023

 

CHAPTER 5. Immunoassay Market By Technology

5.1. Introduction

5.2. Immunoassay Revenue By Technology

5.2.1. Immunoassay Revenue (USD Billion) and Forecast, By Technology, 2020-2032

5.2.2. Enzyme Immunoassay (EIA)s

5.2.2.1. Enzyme Immunoassay (EIA) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.2. Fluorescence Immunoassays (FIA)

5.2.2.2.1. Fluorescence Immunoassays (FIA) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.3. Chemiluminescence Immunoassays (CLIA)

5.2.2.3.1. Chemiluminescence Immunoassays (CLIA) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. Radioimmunoassay (RIA)

5.2.3.1. Radioimmunoassay (RIA) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4. Rapid test

5.2.4.1. Rapid test  Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.5. Others

5.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

 

CHAPTER 6. Immunoassay Market By Product

6.1. Introduction

6.2. Immunoassay Revenue By Product

6.2.1. Immunoassay Revenue (USD Billion) and Forecast, By Product, 2020-2032

6.2.2. Analyzers/instruments

6.2.2.1. Analyzers/instruments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.2. Closed-ended systems

6.2.2.2.1. Closed-ended systems Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.3. Open-ended systems

6.2.2.3.1. Open-ended systems Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Reagents & kits

6.2.3.1. Reagents & kits Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3.2. ELISA Reagents & Kits

6.2.3.2.1. ELISA Reagents & Kits Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3.3. Rapid Test Reagents & Kits

6.2.3.3.1. Rapid Test Reagents & Kits Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3.4. ELISPOT Reagents & Kits

6.2.3.4.1. ELISPOT Reagents & Kits Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3.5. Western Blot Reagents & Kits

6.2.3.5.1. Western Blot Reagents & Kits Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3.6. Other Reagents & Kits

6.2.3.6.1. Other Reagents & Kits Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4. Software & services

6.2.4.1. Software & services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

 

CHAPTER 7. Immunoassay Market By Specimen

7.1. Introduction

7.2. Immunoassay Revenue By Specimen

7.2.1. Immunoassay Revenue (USD Billion) and Forecast, By Specimen, 2020-2032

7.2.2. Blood

7.2.2.1. Blood Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3. Saliva

7.2.3.1. Saliva Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4. Urine

7.2.4.1. Urine Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.5. Others Specimens

7.2.5.1. Others Specimens Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

 

CHAPTER 8. Immunoassay Market By Application

8.1. Introduction

8.2. Immunoassay Revenue By Application

8.2.1. Immunoassay Revenue (USD Billion) and Forecast, By Application, 2020-2032

8.2.2. Endocrinology

8.2.2.1. Endocrinology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.3. Therapeutic Drug Monitoring

8.2.3.1. Therapeutic Drug Monitoring Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.4. Autoimmune diseases

8.2.4.1. Autoimmune diseases Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.5. Infectious disease testing

8.2.5.1. Infectious Disease Testing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.6. Cardiology

8.2.6.1. Cardiology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.7. Oncology

8.2.7.1. Oncology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.8. Others

8.2.8.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

 

CHAPTER 9. Immunoassay Market By End-Use

9.1. Introduction

9.2. Immunoassay Revenue By End-Use

9.2.1. Immunoassay Revenue (USD Billion) and Forecast, By End-Use, 2020-2032

9.2.2. Hospitals

9.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.3. Pharmaceutical and biotech companies

9.2.3.1. Pharmaceutical and Biotech Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.4. Clinical laboratories

9.2.4.1. Clinical Laboratories Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.5. Academic research centers

9.2.5.1. Academic Research Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.6. Blood banks

9.2.6.1. Blood banks Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.7. Others

9.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

 

CHAPTER 10. North America Immunoassay Market By Country 

10.1. North America Immunoassay Market Overview

10.2. U.S.

10.2.1. U.S. Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

10.2.2. U.S. Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.2.3. U.S. Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

10.2.4. U.S. Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

10.2.5. U.S. Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

10.3. Canada

10.3.1. Canada Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

10.3.2. Canada Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.3.3. Canada Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

10.3.4. Canada Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

10.3.5. Canada Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

10.4. North America PEST Analysis

 

CHAPTER 11. Europe Immunoassay Market By Country

11.1. Europe Immunoassay Market Overview

11.2. U.K.

11.2.1. U.K. Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

11.2.2. U.K. Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.2.3. U.K. Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

11.2.4. U.K. Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

11.2.5. U.K. Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

11.3. Germany

11.3.1. Germany Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

11.3.2. Germany Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.3.3. Germany Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

11.3.4. Germany Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

11.3.5. Germany Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

11.4. France

11.4.1. France Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

11.4.2. France Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.4.3. France Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

11.4.4. France Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

11.4.5. France Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

11.5. Spain

11.5.1. Spain Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

11.5.2. Spain Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.5.3. Spain Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

11.5.4. Spain Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

11.5.5. Spain Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

11.6. Rest of Europe

11.6.1. Rest of Europe Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

11.6.2. Rest of Europe Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.6.3. Rest of Europe Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

11.6.4. Rest of Europe Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

11.6.5. Rest of Europe Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

11.7. Europe PEST Analysis

 

CHAPTER 12. Asia Pacific Immunoassay Market By Country

12.1. Asia Pacific Immunoassay Market Overview

12.2. China

12.2.1. China Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

12.2.2. China Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

12.2.3. China Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

12.2.4. China Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

12.2.5. China Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

12.3. Japan

12.3.1. Japan Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

12.3.2. Japan Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

12.3.3. Japan Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

12.3.4. Japan Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

12.3.5. Japan Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

12.4. India

12.4.1. India Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

12.4.2. India Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

12.4.3. India Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

12.4.4. India Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

12.4.5. India Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

12.5. Australia

12.5.1. Australia Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

12.5.2. Australia Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

12.5.3. Australia Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

12.5.4. Australia Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

12.5.5. Australia Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

12.6. South Korea

12.6.1. South Korea Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

12.6.2. South Korea Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

12.6.3. South Korea Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

12.6.4. South Korea Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

12.6.5. South Korea Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

12.7. Rest of Asia-Pacific

12.7.1. Rest of Asia-Pacific Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

12.7.2. Rest of Asia-Pacific Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

12.7.3. Rest of Asia-Pacific Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

12.7.4. Rest of Asia-Pacific Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

12.7.5. Rest of Asia-Pacific Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

12.8. Asia Pacific PEST Analysis

 

CHAPTER 13. Latin America Immunoassay Market By Country

13.1. Latin America Immunoassay Market Overview

13.2. Brazil

13.2.1. Brazil Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

13.2.2. Brazil Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

13.2.3. Brazil Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

13.2.4. Brazil Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

13.2.5. Brazil Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

13.3. Mexico

13.3.1. Mexico Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

13.3.2. Mexico Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

13.3.3. Mexico Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

13.3.4. Mexico Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

13.3.5. Mexico Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

13.4. Rest of Latin America

13.4.1. Rest of Latin America Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

13.4.2. Rest of Latin America Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

13.4.3. Rest of Latin America Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

13.4.4. Rest of Latin America Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

13.4.5. Rest of Latin America Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

13.5. Latin America PEST Analysis

 

CHAPTER 14. Middle East & Africa Immunoassay Market By Country 

14.1. Middle East & Africa Immunoassay Market Overview

14.2. GCC

14.2.1. GCC Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

14.2.2. GCC Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

14.2.3. GCC Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

14.2.4. GCC Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

14.2.5. GCC Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

14.3. South Africa

14.3.1. South Africa Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

14.3.2. South Africa Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

14.3.3. South Africa Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

14.3.4. South Africa Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

14.3.5. South Africa Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

14.4. Rest of Middle East & Africa

14.4.1. Rest of Middle East & Africa Immunoassay Revenue (USD Billion) and Forecast By Product, 2020-2032

14.4.2. Rest of Middle East & Africa Immunoassay Revenue (USD Billion) and Forecast By Technology, 2020-2032

14.4.3. Rest of Middle East & Africa Immunoassay Revenue (USD Billion) and Forecast By Specimen, 2020-2032

14.4.4. Rest of Middle East & Africa Immunoassay Revenue (USD Billion) and Forecast By Application, 2020-2032

14.4.5. Rest of Middle East & Africa Immunoassay Revenue (USD Billion) and Forecast By End-Use, 2020-2032

14.5. Middle East & Africa PEST Analysis

 

CHAPTER 15. Player Analysis Of Immunoassay Market

15.1. Immunoassay Market Company Share Analysis

15.2. Competition Matrix

15.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

15.2.2. New Product Launches and Product Enhancements

15.2.3. Mergers And Acquisition In Global Immunoassay Market

15.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

 

CHAPTER 16. Company Profile

16.1. Thermo Fisher Scientific, Inc

16.1.1. Company Snapshot

16.1.2. Business Overview

16.1.3. Financial Overview

16.1.3.1. Revenue (USD Billion), 2023

16.1.3.2. Thermo Fisher Scientific, Inc, 2023 Immunoassay Business Regional Distribution

16.1.4. Product /Service and Specification

16.1.5. Recent Developments & Business Strategy

16.2. Abbott Laboratories

16.3. bioMérieux SA

16.4. Becton, Dickinson and Company

16.5. Abbott Laboratories

16.6. F. Hoffmann-La Roche AG

16.7. Danaher Corporation (Beckman Coulter)

16.8. Siemens Healthineers

16.9. Quidel Corporation

16.10. Sysmex Corporation

16.11. Bio-Rad Laboratories, Inc

Frequently Asked Questions

How big is the Immunoassay market?

The immunoassay market size was valued at USD 31.4 Billion in 2023.

What is the CAGR of the global Immunoassay market from 2024 to 2032?

The CAGR of Immunoassay is 5.1% during the analysis period of 2024 to 2032.

Which are the key players in the Immunoassay market?

The key players operating in the global market are including Thermo Fisher Scientific, Inc, Abbott Laboratories, bioMérieux SA, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc, F. Hoffmann-La Roche AG, Danaher Corporation (Beckman Coulter), Siemens Healthineers, Quidel Corporation; Sysmex Corporation, and Bio-Rad Laboratories, Inc.

Which region dominated the global Immunoassay market share?

North America held the dominating position in immunoassay industry during the analysis period of 2024 to 2032.

Which region registered fastest CAGR from 2024 to 2032?

Asia-Pacific region exhibited fastest growing CAGR for market of immunoassay during the analysis period of 2024 to 2032.

What are the current trends and dynamics in the global Immunoassay industry?

The current trends and dynamics in the immunoassay industry include rising prevalence of chronic and infectious diseases fuels the demand for immunoassay diagnostics, technological advancements in immunoassay platforms improve accuracy and speed, and growing demand for point-of-care testing (POCT) boosts market adoption.

Which technology held the maximum share in 2023?

The enzyme immunoassay (EIA) held the maximum share of the Immunoassay industry.

Select Licence Type

Single User

US$ 4500

Multi User

US$ 7000

Excel Datapack

US$ 2000

Why Acumen Research And Consulting

100%

Customer Satisfaction

24x7

Availability - we are always there when you need us

200+

Fortune 50 Companies trust Acumen Research and Consulting

80%

of our reports are exclusive and first in the industry

100%

more data and analysis

1000+

reports published till date